Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.24.1.1.u2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Collaboration revenue $ 36,445 $ 18,626 $ 73,700
Operating expenses:        
Research and development 2,167,288 3,816,644 2,811,330 7,562,584
General and administrative 1,701,273 1,884,569 2,354,728 3,788,278
Total operating expenses 3,868,561 5,701,213 5,166,058 11,350,862
Loss from operations (3,868,561) (5,664,768) (5,147,432) (11,277,162)
Other income 4,327,946 4,327,946
Foreign exchange (loss) gain (93,960) (2,303) 16,402 67,949
Net income (loss) $ 365,425 $ (5,667,071) $ (803,084) $ (11,209,213)
Per share information:        
Net income (loss) per share, basic $ 0.08 $ (7.55) $ (0.19) $ (21.14)
Weighted average shares outstanding, basic 4,617,665 750,582 4,205,469 530,131
Net income (loss) per share, diluted $ 0.07 $ (7.55) $ (0.19) $ (21.14)
Weighted average shares outstanding, diluted 4,885,845 750,582 4,205,469 530,131